Andrew Kuykendall, MD

Articles by Andrew Kuykendall, MD

Prithviraj Bose, MDMeeting News | December 30, 2024
The panel moderated by Prithviraj Bose, MD, goes into detail on practical aspects of this agent's use in the clinic.
Prithviraj Bose, MDMeeting News | December 30, 2024
The expert panel moderated by Dr. Bose looks at noteworthy study work on use of this agent for anemia in myelofibrosis.
Prithviraj Bose, MDMeeting News | December 30, 2024
Empaneled experts describe their investigations of momelotinib in a continued discussion moderated by Prithviraj Bose, MD.
Prithviraj Bose, MDMeeting News | December 30, 2024
The expert panel moderated by Prithviraj Bose, MD, tells which research presented at the Meeting they found most exciting.
Prithviraj Bose, MDMyelofibrosis | December 31, 2024
Esteemed experts provide valuable insights into the evolving myelofibrosis landscape and its implications for patient care.
Prithviraj Bose, MDMyelofibrosis | January 14, 2025
Key takeaways from the top ASH abstracts in the myelofbrosis space.
Prithviraj Bose, MDMyelofibrosis | February 6, 2025
A roundtable discussion starts with a conversation about the myelofibrosis treatment landscape.
Andrew Kuykendall, MDPolycythemia Vera | December 13, 2023
Real-world databases lent insight into how often patients with PV experience thromboembolic events.